User profiles for Odile Launay
 | odile launayProfesseur en maladies infectieuses, Université Paris Descartes Verified email at cch.aphp.fr Cited by 17753 |
[HTML][HTML] Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination
…, A Vogt, T Simon, O Launay… - The Journal of …, 2019 - Am Soc Clin Investig
BACKGROUND. Systems vaccinology allows cutting-edge analysis of innate biomarkers of
vaccine efficacy. We explored a strategy to shape the adaptive immune response by …
vaccine efficacy. We explored a strategy to shape the adaptive immune response by …
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
…, V Seror, S Cortaredona, O Launay… - The Lancet infectious …, 2020 - thelancet.com
Just a few weeks ago, more than half of the world's population was on lockdown to limit the
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientists are …
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientists are …
[HTML][HTML] Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19
…, A Ustianowski, S De Wit, O Launay… - … England Journal of …, 2022 - Mass Medical Soc
Background The monoclonal-antibody combination AZD7442 is composed of tixagevimab
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …
[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue
…, V Seror, S Cortaredona, O Launay… - Social science & …, 2020 - Elsevier
As Covid-19 spreads across the world, governments turn a hopeful eye towards research
and development of a vaccine against this new disease. But it is one thing to make a vaccine …
and development of a vaccine against this new disease. But it is one thing to make a vaccine …
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception
Background. The efficacy of preventing perinatal transmission (PT) of human immunodeficiency
virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The …
virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The …
[HTML][HTML] Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study
F Dromer, S Mathoulin-Pélissier, O Launay… - PLoS …, 2007 - journals.plos.org
Background Cryptococcosis is a life-threatening opportunistic fungal infection in both HIV-positive
and -negative patients. Information on clinical presentation and therapeutic guidelines…
and -negative patients. Information on clinical presentation and therapeutic guidelines…
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
JL Bresson, C Perronne, O Launay, C Gerdil, M Saville… - The Lancet, 2006 - thelancet.com
Background Pathogenic avian influenza A virus H5N1 has caused outbreaks in poultry and
migratory birds in Asia, Africa, and Europe, and caused disease and death in people. …
migratory birds in Asia, Africa, and Europe, and caused disease and death in people. …
[HTML][HTML] Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19. Objectives We …
immunocompromised populations, who are at increased risk of severe COVID-19. Objectives We …
[HTML][HTML] Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France
…, F Collange, A Gautier, C Jestin, O Launay… - …, 2015 - thelancet.com
Background This study aimed to assess: 1) vaccine hesitancy (VH) prevalence among French
general practitioners (GPs) through the frequency of their vaccine recommendations, and 2…
general practitioners (GPs) through the frequency of their vaccine recommendations, and 2…
